Ciladopa
- Level
- Commodity
- Parent
- 51142500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142521This classification denotes a dopamine agonist with the molecular formula C21H26N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D09L486R3J, chemically known as 2,4,6-cycloheptatrien-1-one, 2-(4-(2-(3,4-dimethoxyphenyl)-2-hydroxyethyl)-1-piperazinyl)-, (s)- but generally known as ciladopa, which bears US NIH Compound Identifier 133371. European Medicines Agency schedules Ciladopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06262MIG. The term CILADOPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). CILADOPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciladopa under HS 29335995 and SITC 51576. As of Q4 2014, CILADOPA remains the US FDA Preferred Term for this commodity. Ciladopa bears US NLM identifiers UMLS ID C0055722 and NCI Concept Code C79568. SMILES: OC(CN1CCN(CC1)C1C(=O)CCCCC1)C1CC(OC)C(OC)CC1.
Same parent
Under 51142500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.